Precision oncology has just received a boost: a report on the prevalence of mutations in cancer driver genes based on whole genome sequencing of 10,000 clinical cases. The challenge ahead lies in how to explore the data to accelerate new discoveries in cancer biology while advancing precision oncology.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Varmus, H. N. Engl. J. Med. 347, 1526–1527 (2002).
Collins, F. S. & Varmus, H. N. Engl. J. Med. 372, 793–795 (2015).
Bailey, M. H. et al. Cell 173, 371–385 (2018).
Kinnersley, B. et al. Nat Genet. https://doi.org/10.1038/s41588-024-01785-9 (2024).
Kandoth, C. et al. Nature 502, 333–339 (2013).
ICGC/TCGA Pan-Cancer Analysis of Whole Genome Consortium. Nature 578, 82–93 (2020).
Doroshow, D. B. & Doroshow, J. H. Surg. Oncol. Clin. N. Am. 29, 35–49 (2020).
Cerami, E. et al. Cancer Discov. 2, 401–404 (2012).
Pugh, T. J. et al. Cancer Discov. 12, 2044–2057 (2022).
Senkin, S. et al. Nature 629, 910–918 (2024).
Landi, M. T. et al. Am. J. Epidemiol. 190, 962–976 (2021).
Rebbeck, T. R. et al. Cancer Discov. 8, 803–811 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Chanock, S.J. Harnessing cancer genomes for precision oncology. Nat Genet 56, 1768–1769 (2024). https://doi.org/10.1038/s41588-024-01879-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-024-01879-4